Reactive Oxygen Species Responsive Supramolecular Prodrug Eyedrops for the Treatment of Choroidal Neovascularization
Nano Letters · 2024
DOI: 10.1021/acs.nanolett.4c02576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2024. Verfasst von Shuting Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Prodrugs, Reactive Oxygen Species, Ophthalmic Solutions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Excellent Young Scientists Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China.
- Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
- Laboratory of Molecular Engineering and Nanomedicine, Dr. Li Dak-Sum Research Centre, The University of Hong Kong, Hong Kong, China.
ORCID-Profile: Weiping Wang
Förderung
- Excellent Young Scientists Fund
Zitieren
APA
Xu, S., Li, J., Long, K., & Wang, W. (2024). Reactive Oxygen Species Responsive Supramolecular Prodrug Eyedrops for the Treatment of Choroidal Neovascularization. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c02576
Vancouver
Xu S, Li J, Long K, Wang W. Reactive Oxygen Species Responsive Supramolecular Prodrug Eyedrops for the Treatment of Choroidal Neovascularization. Nano Letters. 2024. doi:10.1021/acs.nanolett.4c02576
BibTeX
@article{Xu2024,
author = {Xu, Shuting and Li, Jia and Long, Kaiqi and Wang, Weiping},
title = {Reactive Oxygen Species Responsive Supramolecular Prodrug Eyedrops for the Treatment of Choroidal Neovascularization},
journal = {Nano Letters},
year = {2024},
doi = {10.1021/acs.nanolett.4c02576}
}
EUVIMED